DOYLESTOWN, PA. - July 7, 2008 - The Quigley Corporation (Nasdaq: QGLY)
today announced that the Company was added to the Russell Microcap® Index
when Russell Investment reconstituted its comprehensive family of U.S. indexes
on June 27, 2008.
Membership in the Russell Microcap, which remains in place for one year, means
automatic inclusion in the appropriate growth and value style indexes. Russell
determines membership for its equity indexes primarily by objective,
market-capitalization rankings and style attributes.
Russell indexes are widely used by investment managers and institutional
investors for index funds and as benchmarks for both passive and active
investment strategies. An industry-leading $4.4 trillion in assets currently
are benchmarked to them.
Guy J. Quigley, Chairman, President and Chief Executive Officer stated, "We are
pleased to be included in the Russell Microcap® Index and the opportunity
it provides us to increase our visibility within the investment community."
Annual reconstitution of Russell indexes captures the 4,000 largest U.S. stocks
as of the end of May, ranking them by total market capitalization to create the
Russell 3000® Index and Russell Microcap. These investment tools
originated from Russell's multi-manager investment business in the early 1980s
when the company saw the need for a more objective, market-driven set of
benchmarks in order to evaluate outside investment managers.
About Russell Russell Investments aims to improve financial security for people
by providing strategic advice, world- class implementation, state-of-the-art
performance benchmarks, and a range of institutional-quality investment
products. With more than $213 billion in assets under management, Russell
serves individual, institutional and advisor clients in more than 40 countries.
Russell provides access to some of the world’s best money managers. It helps
investors put this access to work in corporate defined benefit and defined
contribution plans, and in the life savings of individual investors. Founded in
1936, Russell is a subsidiary of Northwestern Mutual Life Insurance Company.
Headquartered in Tacoma, Wash., U.S., Russell has principal offices in
Amsterdam, Auckland, Hong Kong, Johannesburg, London, Melbourne, New York,
Paris, San Francisco, Singapore, Sydney, Tokyo and Toronto.
About The Quigley Corporation
The Quigley Corporation (NASDAQ: QGLY,
http://www.Quigleyco.com) is a diversified natural health medical science
company. Its Cold Remedy segment is a leading marketer and manufacturer of the
COLD-EEZE® family of lozenges, gums and sugar free tablets clinically
proven to cut the common cold nearly in half. COLD-EEZE customers include
leading national wholesalers and distributors, as well as independent and chain
food, drug and mass merchandise stores and pharmacies. The Quigley Corporation
has wholly owned subsidiaries; Quigley Manufacturing Inc. consists of two FDA
approved facilities to manufacture COLD-EEZE® lozenges as well as fulfill
other contract manufacturing opportunities and Quigley Pharma Inc.
(http://www.QuigleyPharma.com) conducts research in order to develop and
commercialize a pipeline of patented botanical and naturally derived potential
prescription drugs.
Forward-Looking Statements
Certain statements in this press release are
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995 and involve known and unknown risk,
uncertainties and other factors that may cause the Company's actual performance
or achievements to be materially different from the results, performance or
achievements expressed or implied by the forward-looking statement. Factors
that impact such forward-looking statements include, among others, changes in
worldwide general economic conditions, changes in interest rates, government
regulations, and worldwide competition.
